Percutaneous hepatic perfusion with melphalan in uveal melanoma: A safe and effective treatment modality in an orphan disease

BACKGROUND: Metastatic uveal melanoma (UM) carries a poor prognosis; liver is the most frequent and often solitary site of recurrence. Available systemic treatments have not improved outcomes. Melphalan percutaneous hepatic perfusion (M‐PHP) allows selective intrahepatic delivery of high dose cytoto...

Descripción completa

Detalles Bibliográficos
Autores principales: Karydis, Ioannis, Gangi, Alexandra, Wheater, Matthew J., Choi, Junsung, Wilson, Iain, Thomas, Kerry, Pearce, Neil, Takhar, Arjun, Gupta, Sanjay, Hardman, Danielle, Sileno, Sean, Stedman, Brian, Zager, Jonathan S., Ottensmeier, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6033148/
https://www.ncbi.nlm.nih.gov/pubmed/29284076
http://dx.doi.org/10.1002/jso.24956

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6033148/
https://www.ncbi.nlm.nih.gov/pubmed/29284076
http://dx.doi.org/10.1002/jso.24956

Ejemplares similares